This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Amyloid Beta Peptides Inhibit Glucose Transport at the Blood-brain Barrier by Disrupting Insulin-Akt Pathway in Alzheimers Disease
- Relevance of Measurement Uncertainty for Quantitative Response Assessment of Breast Cancer Bone Metastases with 18F-Fluoride
- Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?
- Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans
- Understanding SUV Variability in Reference Tissue for 18F-FDG PET with a Simple Measurement Model
- 18F-FDG Uptake to Assess Eosinophilic Inflammation in Asthma: Would SUV at Late Imaging Be Relevant?
- Is Liver SUV Stable over Time in 18F-FDG PET Imaging?
- Searching for Alternatives to Full Kinetic Analysis in 18F-FDG PET: An Extension of the Simplified Kinetic Analysis Method
- A Curve-Fitting Approach to Estimate the Arterial Plasma Input Function for the Assessment of Glucose Metabolic Rate and Response to Treatment
- Is the Physical Decay Correction of the 18F-FDG Input Function in Dynamic PET Imaging Justified?
- Standards for PET Image Acquisition and Quantitative Data Analysis
- The Effect of Renal Failure on 18F-FDG Uptake: A Theoretic Assessment
- Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors
- Image-Derived Input Function for Assessment of 18F-FDG Uptake by the Inflamed Lung
- Partial-Volume Effect in PET Tumor Imaging
- Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
- Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer
- Comparison of Methods to Quantitate 18F-FDG Uptake with PET During Experimental Acute Lung Injury
- Simplified Kinetic Analysis of Tumor 18F-FDG Uptake: A Dynamic Approach
- 18F-FDG PET Evaluation of the Response to Therapy for Lymphoma and for Breast, Lung, and Colorectal Carcinoma
- 18F-FDG in Cardiology and Oncology: The Bitter with the Sweet
- Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET